US5302372A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method to opacify left ventricle in echocardiography
Assignee: National Science and Technology Council
•
Filing: 1992-07-27
•
Granted: 1994-04-12
•
Expires: 2012-07-27
Abstract
Abstract An echo contrast agent for use in echocardiography is disclosed which can be introduced into the body through peripheral venous injection to opacify left ventricle. The echo agent to be injected into the body contains a plurality of gas-in-liquid microbubbles which are smaller than red blood cells and can therefore traverse the pulmonary circulation to reach the left ventricle in substantial quantity to effectuate opacification thereof. The echo contrast agent disclosed in this invention contains: (a) an aqueous solution containing 0.40-0.60 grams of albumin and 4.0-10.0 grams of glucose per 10 ml solution mixed with (b) glycerin. The ratio between (b) and (a) should be no less than 0.050. A method for preparing this echo contrast agent was also disclosed.
Inventors
- 👤 Shoa-Lin Lin
- 👤 Chung-Yuan Mou
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 13:54
CPC Classifications
A; A61; A61K; A61K49/00; A61K49/22; A61K49/222; A61K49/223
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
106 words
A method to opacify left ventricle comprising the steps of: (a) obtaining an echo contrast agent which comprises: (i) an aqueous albumin-glucose solution containing 0.40 to 0.60 grams of albumin and 4.0 to 10.0 grams of glucose per 10 ml of said aqueous albumin-glucose solution; and (ii) glycerin having a volume ratio between said glycerin and said aqueous albumin-glucose solution of no less than 0.050; (b) sonicating said echo contrast agent from step (a); (c) introducing said sonicated echo contrast agent into a body through peripheral venous or inferior vena cava injection; and (d) performing an echocardiographic study on said body using an appropriate echocardiographic machine.
Claim 2
Independent Claim
106 words
A method to opacify left ventricle comprising the steps of: (a) obtaining an echo contrast agent which comprises: (i) an aqueous albumin-glucose solution containing 0.40 to 0.60 grams of albumin and 4.0 to 10.0 grams of glucose per 10 ml of said aqueous albumin-glucose solution; and (ii) glycerin having a volume ratio between said glycerin and said aqueous albumin-glucose solution of no less than 0.050; (b) sonicating said echo contrast agent from step (a); (c) introducing said sonicated echo contrast agent into a body through peripheral venous or inferior vena cava injection; and (d) performing an echocardiographic study on said body using an appropriate echocardiographic machine.
Claim 3
Dependent Claim
46 words
The method to opacify left ventricle of claim 1 wherein said aqueous albumin-glucose solution contains 0.5 grams of albumin and 5.0 grams of glucose per 10.0 ml of said aqueous albumin-glucose solution and said volume ratio between said glycerin and said aqueous albumin-glucose solution is 0.060.
Claim 4
Dependent Claim
19 words
The method to opacify left ventricle of claim 1 wherein said sonication step generates a plurality of gas-in-liquid microbubbles.
Claim 5
Dependent Claim
21 words
The method to opacify left ventricle of claim 3 wherein said microbubbles have diameters ranging approximately from 1 to 9 microns.
Claim 6
Dependent Claim
20 words
The method to opacify left ventricle of claim 3 wherein said microbubbles have a mean diameter of approximately 5.0 microns.
Claim 7
Dependent Claim
39 words
The method to opacify left ventricle of claim 3 wherein said microbubbles can be introduced into a body through peripheral venous injection and are capable of traversing the pulmonary circulation of said body without losing a significant portion thereof.
Claim 8
Dependent Claim
40 words
The method to opacify left ventricle of claim 3 wherein said microbubbles can be introduced into said body through inferior vena cava injection and are capable of travelling the pulmonary circulation of said body without losing a signification portion thereof.
Claim 9
Dependent Claim
32 words
The method to opacify left ventricle of claim 3 wherein said microbubbles are generated with an ultrasonic sonication device which generates a sound wave having frequencies in the range between 10-30 KHz.
Claim 10
Independent Claim
138 words
A method to opacify left ventricle in an ultrasonic echocardiography, said method comprises the steps of: (a) preparing an aqueous albumin-glucose solution by adding, per every 10 ml of said aqueous albumin-glucose solution, 0.40-0.60 grams of albumin, 4.0-10.0 grams of glucose, and appropriate amount of distilled water to make up the 10.0 ml volume; (b) adding glycerin to said aqueous albumin-glucose solution in a volume ratio between said glycerin and said aqueous albumin-glucose solution of no less than 0.050; (c) sonicating said aqueous albumin-glucose solution from step (b) after said glycerin is settled to the bottom thereof to generate a plurality of microbubbles; (d) introducing said sonicated aqueous albumin-glucose solution from step (c) into a body through peripheral venous or inferior vena cava injection; and (e) performing an echocardiographic study on said body using an appropriate echo machine.
Claim 11
Independent Claim
138 words
A method to opacify left ventricle in an ultrasonic echocardiography, said method comprises the steps of: (a) preparing an aqueous albumin-glucose solution by adding, per every 10 ml of said aqueous albumin-glucose solution, 0.40-0.60 grams of albumin, 4.0-10.0 grams of glucose, and appropriate amount of distilled water to make up the 10.0 ml volume; (b) adding glycerin to said aqueous albumin-glucose solution in a volume ratio between said glycerin and said aqueous albumin-glucose solution of no less than 0.050; (c) sonicating said aqueous albumin-glucose solution from step (b) after said glycerin is settled to the bottom thereof to generate a plurality of microbubbles; (d) introducing said sonicated aqueous albumin-glucose solution from step (c) into a body through peripheral venous or inferior vena cava injection; and (e) performing an echocardiographic study on said body using an appropriate echo machine.
Claim 12
Dependent Claim
42 words
The method of claim 9 wherein said aqueous albumin-glucose solution contains 0.5 grams of albumin and 5.0 grams of glucose per 10.0 ml of said aqueous albumin-glucose solution and said volume ratio between said glycerin and said aqueous albumin-glucose solution is 0.060.
Claim 13
Dependent Claim
28 words
The method of claim 9 wherein said microbubbles are capable of being introduced into a body through peripheral venous injection and traverse the pulmonary circulation of said body.
Claim 14
Dependent Claim
29 words
The method of claim 9 wherein said microbubbles are capable of being introduced into a body through inferior vena cava injection and traverse the pulmonary circulation of said body.
Claim 15
Dependent Claim
17 words
The method of claim 9 wherein said microbubbles have diameters ranging approximately from 1 to 9 microns.
Claim 16
Dependent Claim
20 words
The method to opacify left ventricle of claim 9 wherein said microbubbles have a mean diameter of approximately 5.0 microns.
Claim 17
Dependent Claim
19 words
The method to opacify left ventricle of claim 9 wherein said microbubbles are generated using an ultrasonic sonication device.
Claim 18
Dependent Claim
26 words
The method to opacify left ventricle of claim 15 wherein said ultrasonic sonication device generates a sound wave having frequencies in the range between 10-30 KHz.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-04-11 | 1997-10-11 | 1998-04-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-04-11 | 2001-10-11 | 2002-04-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-04-11 | 2005-10-11 | 2006-04-12 | $7700.00 | Window Closed / Lapsed |